Henan TCM College, Zhengzhou 450008, China.
J Tradit Chin Med. 2011 Mar;31(1):32-5. doi: 10.1016/s0254-6272(11)60007-1.
To observe the therapeutic effects of Jingyuankang capsules for leukopenia in AIDS patients.
In this randomized double-blind trial, 58 patients orally took Jingyuankang capsule, analog Leucogen tablet and the HAART (highly active anti-retroviral therapy) drugs, and the other 58 patients took Leucogen tablet, analog Jingyuankang capsule and the HAART drugs all for 6 months, during which the peripheral hemogram was periodically examined to observe the therapeutic effects of Jingyuankang capsule for leukopenia of the AIDS patients.
With good therapeutic effect for leukopenia of the AIDS patients, Jingyuankang capsule can enhance leukocyte level as effective as Leucogen tablet in treating grade I and grade II leukopenia, and more effectively than Leucogen tablet in treating grade III leukopenia. No toxic side-effects and adverse reactions were found during the treatment and in the follow-up visit.
Jingyuankang capsule can effectively treat leukopenia of the AIDS patients.
观察降脂康胶囊治疗艾滋病患者白细胞减少症的疗效。
本研究采用随机双盲对照试验，将 58 例艾滋病患者分为两组，分别口服降脂康胶囊、模拟利可君片和高效抗逆转录病毒治疗（HAART）药物，以及利可君片、模拟降脂康胶囊和 HAART 药物，疗程均为 6 个月，定期检查外周血象，观察降脂康胶囊治疗艾滋病患者白细胞减少症的疗效。
降脂康胶囊治疗艾滋病患者白细胞减少症疗效确切，在治疗Ⅰ、Ⅱ级白细胞减少症方面与利可君片疗效相当，在治疗Ⅲ级白细胞减少症方面优于利可君片。治疗过程中和随访期间均未发现毒副作用及不良反应。
降脂康胶囊可有效治疗艾滋病患者白细胞减少症。
